David Leslie Szekeres Heron Therapeutics, Inc. (HRTX) insider trading activity

David Leslie Szekeres is EVP, Chief Operating Officer of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 33,754 shares of HRTX, which is worth approximately $60,082. The most recent transaction as insider was on Jan 13, 2021, when has been sold 1,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.8K

0% 3M change

0% 12M change

Total Value Held $60,082

David Leslie Szekeres Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 13 2021	BUY Exercise of conversion of derivative security	-	1,250 Added 50.0%	1,250 Common Stock
Jan 08 2021	SELL Open market or private sale	$70,206 $19.66 p/Share	3,571 Reduced 100.0%	0 Common Stock

Also insider at

VLON

Vallon Pharmaceuticals, Inc. Healthcare

Director

DLS